{{Rsnum
|rsid=833060
|Chromosome=6
|position=43767412
|Orientation=plus
|GMAF=0.2893
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 50.8 | 38.5 | 10.8
| HCB | 24.4 | 60.0 | 15.6
| JPT | 29.5 | 61.4 | 9.1
| YRI | 73.0 | 22.2 | 4.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 24.4 | 60.0 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19741061
|Title=VEGF gene haplotypes are associated with sarcoidosis
}}

{{PMID|17319747|OA=1
}} Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}